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Human serum albumin (HSA) was subjected to oxidative stress and the locations of the
resulting protein carbonyls were determined using mass spectrometry in conjunction with a
hydrazide labeling scheme. To model oxidative stress, HSA samples were subjected to
metal-catalyzed oxidation (MCO) conditions or treated with hypochlorous acid (HOCl).
Oxidation led to the conversion of lysine residues to 2-aminoadipic semi-aldehyde residues,
which were subsequently labeled with biotin hydrazide. Analysis of the tryptic peptides from
the samples indicates that the oxidations are highly selective. Under MCO conditions, only two
of the 59 lysine residues appeared to be modified (Lys-97 and Lys-186). With HOCl, five
different lysine modification sites were identified (Lys-130, Lys-257, Lys-438, Lys-499, and
Lys-598). These results strongly suggest that the preferred site of modification is dependent on
the nature of the oxidant and that the process relies on specific structural motifs in the protein
to direct the oxidation. The high selectivity seen here provides insights into the factors that in
vivo drive the selective carbonylation of specific proteins in systems under oxidative
stress. (J Am Soc Mass Spectrom 2006, 17, 1172–1180) © 2006 American Society for Mass
SpectrometryIt is well established that oxidative stress leads to avariety of protein modifications including carbony-lation [1– 4]. In particular, protein carbonyls have
been identified as key biomarkers for disease [5–7] and
aging [8 –11]. Oxidation of the side-chain functional
groups of lysine (Scheme 1), arginine, and proline to
aldehyde groups (as well as threonine to a ketone) are
common means of generating protein carbonyls [12, 13].
Studies by a number of workers, including Sohal [14 –
17], have shown that protein carbonylation is selective
and that only a subset of proteins is modified in systems
under oxidative stress [18 –26]. The underlying reasons
behind this selectivity are not well understood. Al-
though protein carbonylation has been characterized in
numerous systems under a variety of conditions [27–
29], these studies only have targeted total carbonyl
levels and the distribution between bound and free
carbonyl species [30]. Only recently have data emerged
on the specific sites of carbonylation in proteins sub-
jected to oxidative stress [31–33]. The best data come
from recent work by Mirzaei and Regnier [31, 32], who
have identified carbonylation sites in proteins isolated
from yeast and rats subjected to in vivo oxidative stress
and in model protein oxidation systems. The sites of
protein carbonylation represents an important issue
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tion of proteins in vivo are likely to be manifested in the
carbonylation site selectivity of a given protein. It is our
hypothesis that the carbonylation of a protein is site
selective and that structural features in the protein will
determine the preferred sites of carbonylation.
Although headway has been made in identifying the
sites of other oxidative modifications in proteins such as
histidine oxidation [34 –39] and tyrosine nitration [40,
41], the development of techniques for identifying car-
bonylation sites in proteins has lagged behind. The high
reactivity of aldehydes, particularly in the presence of
the nucleophilic groups typically found in peptides,
complicates their identification and therefore a tagging
procedure is needed to protect the functional group for
subsequent analysis.
In the present contribution, we describe a mass
spectrometric analysis of human serum albumin (HSA)
subjected to in vitro oxidative stress. Our methodology
is based on that developed by Regnier and coworkers
[26, 31] recently. We have chosen HSA because serum
albumin is a known target of in vivo protein carbony-
lation [42]. Oxidative stress was simulated by subjecting
the protein to metal-catalyzed oxidation (MCO) condi-
tions as well as direct treatment with hypochlorous acid
(HOCl). After oxidation, biotin hydrazide followed by
NaBH3CN was used to label and protect the protein
carbonyls in the samples as hydrazines (Scheme 2). In
this study, the labeling was simply used to stabilize the
oxidative modifications. The biotin label was chosen
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means of concentrating the oxidized protein. Mass
spectrometric analysis of peptides from proteolytic di-
gests of the oxidized/labeled proteins allowed for the
identification of the specific sites of modification. In
these studies, we have focused on two modifications
leading to carbonyls, the oxidation of lysine to 2-
aminoadipic semi-aldehyde (Scheme 1) and the oxida-
tion of arginine to glutamic semi-aldehyde. The oxidiz-
ing conditions employed here are expected to generate
other protein modifications such as hydroxylation,
chlorination, and oxygen addition (i.e., methionine or
histidine oxide formation), but the present study will
only focus on carbonylation because site selectivity is
our area of greatest interest and it has been studied the
least in the past. As a part of the analysis of the data, we
have correlated the locations of the carbonylation sites
with structural features in the protein.
Materials and Methods
Materials
Human serum albumin (HSA), biotin hydrazide, and
2,4-dinitrophenylhydrazine (2,4-DNPH) were pur-
chased from Sigma (St. Louis, MO). Sodium cyanoboro-
hydride (5 M solution in aqueous 1 M sodium hydrox-
ide) was obtained from Sigma-Aldrich (St. Louis, MO).
Sodium hypochlorite (4–6% NaOCl) was purchased
from Fisher Scientific (Fair Lawn, NJ). Sequencing
grade, modified trypsin used for the enzymatic diges-
tion was obtained from Promega (Madison, WI). Chy-
motrypsin and endoproteinase Glu-C were obtained
from Roche (Indianapolis, IN). All other chemicals and
solvents were obtained from commercial sources and
were of the highest purity available.
Oxidation of HSA
Metal-catalyzed oxidation. HSA (100 mg) was dis-
solved at a concentration of 10 mg/mL in oxidation
buffer (50 mM HEPES, N-2-hydroxyethylpiperazine-
N=-2- ethanesulfonic acid buffer, pH 7.4, containing
100 mM KCl and 10 mM MgCl2). The oxidation
mixture was prepared by adding neutral ascorbic
acid and FeCl3 to a final concentration of 25 mM and
100 M, respectively. The mixture was incubated for
72 h at 37 °C in a water bath, after which oxidation
was terminated by addition of EDTA (ethylenediami-
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Scheme 1. Oxidation of lysine residue to 2-aminoadipic semi-
aldehyde.netetraacetic acid) to 1 mM [26, 43].HOCl oxidation. HSA (20 mg) was dissolved at a
concentration of 2 mg/1 mL in HPLC-grade water.
Oxidation was performed by adding NaOCl to a final
concentration of 5 mM. The mixture was incubated for
15 min at 37 °C in a water bath [30]. Following the
oxidation, HOCl was removed by diluting the sample
with PBS (phosphate-buffered saline) buffer (pH 7.4)
and filtering the solution through a Microcon YM-30
filter device. Filtration was accomplished by centrifuga-
tion of the Microcon assembly at 8000 rpm for about 5
to 10 min. The dilution/centrifugation process was
repeated four times and subsequently the oxidized HSA
sample was dried using a Speed-Vac concentrator.
For both oxidation protocols, controls were prepared
by dissolving HSA in HEPES buffer (for MCO oxida-
tion) or in HPLC-grade water (for HOCl oxidation) and
then incubated at 37 °C in a water bath.
Quantification of Protein Carbonyls in Oxidized
HSA
The carbonyl content in oxidized HSA (MCO-HSA and
HOCl-HSA) was quantified according to the method
developed by Levine et al. [44]. In this method, carbonyl
group concentrations were determined by conversion
to the corresponding hydrazones by reaction with 10
mM 2,4-DNPH (protein/2,4-DNPH ratio of 1:5 (vol/
vol) for MCO-HSA and protein/2,4-DNPH ratio of 1:1
(vol/vol) for HOCl-HSA). The reaction mixture was
incubated at room temperature for 1 h, with vortexing
every 10 min. The protein was then precipitated with
trichloroacetic acid (final concentration 10% vol/vol)
and incubated in an ice bath for 30 min. Subsequently,
the solution was subjected to centrifugation at 11,000 
g for 3 min, and the supernatant was discarded. The
precipitated protein was washed three times with eth-
anol-ethyl acetate (1:1), and then was dissolved in 1 mL
of 6 M guanidine-HCl solution (pH 2.3). The carbonyl
content was calculated from absorbance at 370 nm
using a molar absorption coefficient () of 22,000 M1
cm1 [26].
Biotinylation of Protein Carbonyls
Biotinylation of carbonyl groups in the two types of
oxidized HSA (MCO-HSA and HOCl-HSA) was per-
formed by reaction with biotin hydrazide using an
approach based on the method of Yoo and Regnier [26].
In summary, the oxidized protein samples were dried
using a Speed-Vac Concentrator, then dissolved at a
concentration of 2 mg/mL in PBS buffer (pH 7.4)
containing 5 mM biotin hydrazide. The samples were
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biotinScheme 2. Labeling of 2-aminoadipic semi-aldehyde.
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then cooled to 0 °C. An equal volume of 30 mM sodium
cyanoborohydride in PBS buffer was subsequently
added to stabilize the reaction products [26]. Following
the biotin labeling, the HSA samples were precipitated
with 20% trichloroacetic acid in an ice bath for 1 h, and
the excess reagents were removed as a part of superna-
tant. The pellets were washed three times with ethanol-
ethyl acetate (1:1) and then dissolved in ammonium
bicarbonate buffer in preparation for enzymatic diges-
tion. In a set of test runs, the biotinylated protein
samples were preconcentrated by using a monomeric
avidin column (Pierce Biotechnology, Rockford, IL) to
separate out the biotinylated proteins. This process did
not result in enhanced sensitivity in the LC/MS runs.
Because we are working with a single protein with
moderately high levels of oxidation, it is not surprising
that this preconcentration scheme offered little advan-
tage. The avidin preconcentration was not used in
production runs.
Enzymatic Digestion
The biotinylated HSA samples in 50 mM ammonium
bicarbonate buffer at a concentration of 1 mg/mL were
reduced with 30 mM dithiothreitol at 50 °C for 20 min
and alkylated with 55 mM iodoacetamide at room-
temperature for 30 min in the dark. The excess of
dithiothreitol and iodoacetamide were removed using a
Microcon YM-30 filter device at 8000  g for 15 min.
The proteins were redissolved in 50 mM ammonium
bicarbonate, and subsequently digested with trypsin
(substrate/enzyme ratio of 40/1, wt/wt) at 37 °C for
24 h. The digestion was terminated by adding 0.1%
formic acid (120 L), and the solution was stored at
20 °C. To increase the amino acid sequence coverage,
proteins were also digested with chymotrypsin (sub-
strate/enzyme ratio of 50:1, wt/wt) and endoproteinase
Glu-C (substrate/enzyme ratio of 50:1, wt/wt). In most
work, we have used urea to increase the sequence
coverage in digestions. However, we have found that in
the specific case of human serum albumin, addition of
urea does not have a significant effect on in the se-
quence coverage in sample digestions (more than 81%
sequence coverage is obtained). Therefore, we did not
use urea in our experimental procedures.
Identification of Modified Lys Residues and Tryptic
Peptide Sequences by LC/ESI-MS/MS Analysis
Liquid chromatography/electrospray ionization-tandem
mass spectrometry (LC/ESI-MS/MS) analysis of di-
gested HSA samples (50 pmol/injection) was per-
formed using a capillary HPLC system (Micro-Tech
Scientific, Vista, CA) connected to an LCQ ion trap mass
spectrometer (ThermoFinnigan, San Jose, CA) with a
nanospray source [45]. Tryptic peptides were separated
by reverse-phase chromatography on a C18 column (75m  100 mm; Nucleosil, 5 m particle size) at a flow
rate of 0.3 l/min. The digested peptides were eluted
from the column using a mobile phase A (0.1% formic
acid in water) and a mobile phase B (0.1% formic acid in
acetonitrile) with a three-step linear gradient. The gra-
dient was held for the first 10 min at 5% B, then
increased to 35% B in the next 45 min, and finally
increased to 50% B in the last 10 min. The eluted
peptides (singly, doubly, or triply charged ions) were
analyzed using a data-dependent scan procedure with a
cyclic series of three different scan modes: a full scan
mode (to obtain the most intense peak), followed by a
zoom scan mode (to determine the charged state of the
precursor ion), and finally an MS/MS scan mode (to
determine the structural fragment ions of the precursor
ion). To exclude the redundant processing of a few
dominant ions in the MS/MS analyses, a dynamic
exclusion feature was used that only allows a particular
m/z value to be processed twice in a 2 min time window.
To ensure that low abundance, oxidized lysine or
arginine containing peptides were not left out from our
detection scheme, data dependent scan experiments
also were completed targeting a list of 50 potential
peptide masses that might be expected based on the
protein sequence. The acquired MS/MS spectra were
then searched against the NCBI nonredundant protein
database using the Finnigan Bioworks v.3.2 (Sequest)
software. The database searching was set to only con-
sider peptides within the mass range 500–4000 Da. Up
to two missed cleavage sites were allowed, and cys-
teines were defined as modified with carbamidomethy-
lation. To search for oxidized peptides, the differential
modifications of methionine, histidine, threonine,
serine, proline, lysine, and arginine were set to 16, 16,
240, 258, 241, and 199 Da, respectively. The masses of
modifications can be found in UNIMOD web site
(www.unimod.org).
Experiments (i.e., oxidation. labeling, and analy-
sis) were repeated at least two times (generally three)
to ensure reproducibility in the data. In addition,
control experiments were completed in the absence of
oxidants.
Results
HSA is a 66 kDa protein with 59 lysine and 24 arginine
residues in its secreted form. Its precursor protein
contains 609 amino acids (SwissProt P02768), whereas
the secreted form is missing the first 24 residues and
contains 585 amino acids. Throughout the discussion,
residue numbers from the precursor protein will be
used and these designators will be 24 units larger than
those for the active protein. A sequence map for HSA is
given in Figure 1. Crystal structures have been solved
for HSA and they will be employed in the discussion of
structural motifs [46, 47].
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The oxidation of HSA under MCO conditions was
efficient and on the basis of 2,4-dinitrophenylhydrazine
assays, produced an approximate yield of 45 nmol of
bound carbonyls per mg of protein. Because hypochlo-
rous acid is a more active oxidant, shorter reaction
times were used and higher yields of bound carbonyls
were obtained (120 nmol per mg of protein). These
levels are consistent with previous yields from in vitro
protein oxidations [26, 30, 48].
Analysis of HSA Subjected to MCO Conditions
The oxidation of a lysine or arginine residue followed
by reductive labeling with biotin hydrazide leads to a
predictable increase in the mass of the residue. In the
case of a lysine residue, it is converted to 2-aminoadipic
semi-aldehyde by the oxidation (net mass loss of 1 Da).
The biotin hydrazide label, after reduction of the inter-
mediate hydrazone with NaBH3CN, adds 242 Da for a
net mass shift of 241 Da compared to lysine. In the case
of arginine, the oxidation and labeling causes a mass
shift of 199 Da compared to the starting residue mass.
These altered masses then are incorporated into the
BIOWORKS program used to automatically interpret
1
32
63
94
123
152
184
213
243
273
305
337
367
399
430
460
491
520
552
583
MKWVTFISLLFLFSSAYSRGVFRRDAHKSEV 
AHRFKDLGEENFKALVLIAFAQYLQQCPFED 
HVKLVNEVTEFAKTCVADESAENCDKSLHTL 
FGDK97LCTVATLRETYGEMADCCAKQEPER 
NECFLQHK130DDNPNLPRLVRPEVDVMCTAF 
HDNEETFLKKYLYEIARRHPYFYAPELLFFAK 
RYK186AAFTECCQAADKAACLLPKLDELRDE 
GKASSAKQRLKCASLQKFGERAFKAWAVAR 
LSQRFPKAEFAEVSK257LVTDLTKVHTECCHG 
DLLECADDRADLAKYICENQDSISSKLKECCE 
KPLLEKSHCIAEVENDEMPADLPSLAADFVES
KDVCKNYAEAKDVFLGMFLYEYARRHPDYS
VVLLLRLAKTYETTLEKCCAAADPHECYAKVF
DEFKPLVEEPQNLIKQNCELFEQLGEYKFQN 
ALLVRYTKK438VPQVSTPTLVEVSRNLGKVGS 
KCCKHPEAKRMPCAEDYLSVVLNQLCVLHEK
TPVSDRVTK499CCTESLVNRRPCFSALEVDE 
TYVPKEFNAETFTFHADICTLSEKERQIKKQT 
ALVELVKHKPKATKEQLKAVMDDFAAFVEKC 
CKADDKETCFAEEGKK598LVAASQAALGL
Figure 1. Amino acid sequence of human serum albumin pre-
cursor protein (SwissProt P02768). Lysines modified by MCO
shown in bold and lysines modified by HOCl shown in bold
italics.the tandem mass spectra generated for the peptidesfrom the tryptic digests of the oxidized protein. The
combined digest data provided greater than 93% se-
quence coverage for the samples subjected to MCO. As
a result, the great majority of lysine and arginine
residues in HSA was characterized in the peptide
mixtures from the digests (54/59 lysines and 20/24
arginines were observed).
Using the SEQUEST algorithm in the BIOWORKS
software package, we identified two peptides from
HSA with mass shifts consistent with lysine modifica-
tions. These peptides spanned residues 89–105 and
185–198. The latter peptide gave a weaker relative
signal (7-fold less intense), which was difficult to detect
and suggests that it is a less common modification in
the protein. The peptide containing biotinylated Lys-97
(AA 89–105) was detected at m/z 1087.1 for a doubly-
charged ion (Figure 2), which matches well the calcu-
lated mass of 2173.2 Da. To confirm the modification
sites in these peptides, fragmentation spectra (MS/MS)
were used. MS/MS analysis of the precursor ion at m/z
1087.1 (Figure 3) leads to a fairly comprehensive set of
singly-charged y and b ions (y4–y15 and b4–b6, b8–b16).
These fragment ions clearly confirm the sequence of the
peptide. The large mass gap (label  Lys, 241  128 
369 Da) between the y8 and the y9 ions (as well as the
gap between the b8 and b9 ions) verifies that Lys-97 was
modified and contains the biotin label. The modified
lysine in this peptide was skipped in the tryptic digest
and formally represents a missed cleavage point. We
did locate a nonoxidized peptide spanning residues
89–97 (no missed cleavage points) and it exhibited a
higher intensity (20-fold) than the modified peptide
spanning residues 89–105; however, the modification
can affect ionization efficiency, so an accurate quantita-
tive comparison is not possible. The peptide spanning
residues 185–198 was also detected as a doubly proton-
ated ion at m/z 952.6. The fragmentation spectrum
(Figure 4) shows a less complete set of b and y ions, but
the data are sufficient to confirm the sequence of the
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Figure 2. Full scan mass spectrum and the corresponding inset
zoom scan of the AA# 89-105 containing peptide. This figure
shows that Lys-97 is labeled with biotin with a doubly charged ion
at m/z 1087.1. The asterisk represents the biotin labeled Lys-97.
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modified lysine represents a missed cleavage point.
This lysine is located near the N-terminus of the peptide
at Lys residue number 186. Despite the low signals
associated with this modified peptide, it was possible to
identify it in replicate runs.
In addition to the oxidation of lysine, mass spectrom-
etry also provided evidence of methionine oxidation in
the protein. However, we did not identify any examples
of arginine oxidation to glutamic semi-aldehyde under
these conditions, despite the presence of 24 arginine
residues in HSA.
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Figure 3. MS/MS spectrum of the AA# 89-105 containing pep-
tide. The corresponding MS/MS spectrum for m/z 1087.1 confirms
that the dominant fragments, yn (n  8-15), b8, and b10, arise from
the biotin-labeled Lys-97 containing peptide, with the mass dif-
ference between y9 and y8 equals a molecular mass of 128 (Lys) 
241 (biotin)  369 Da.
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Figure 4. MS/MS spectrum of the AA# 185-198 containing
peptide confirms that Lys-186 is modified with biotin reagent.Analysis of HSA Subjected to HOCl
There was good sequence coverage (86%) from the
combined digest data on the samples from the oxida-
tion of HSA with HOCl. The somewhat lower coverage
in the HOCl samples is probably a result of the stronger
oxidant causing a broader range of predictable as well
as unpredictable modifications to the protein, which
resulted in more complex digest mixtures. Nonetheless,
the great majority of lysines and arginines was ob-
served (49/59 lysines and 17/24 arginines were ob-
served). In the analysis of HOCl-oxidized protein with
the LCQ, a greater number of modified peptides was
identified. Five peptides, spanning residues 123–138,
250–264, 438–452, 497–508, and 598–609, had masses
consistent with a labeled lysine. In this case, all the
peptides had fairly similar intensities, which were less
intense than related nonoxidized peptides. Fragmenta-
tion spectra for these peptides are shown in Figure 5,
Figure 6, Figure 7, Figure 8, and Figure 9. The MS/MS
spectrum of m/z 1119.8 generated from the doubly-
protonated peptide spanning residues 123–138 (Figure
5) shows a large gap (369 Da) between its y7 and y8 ions,
and between its b7 and b8 ions that demonstrates that
Lys130 is modified with biotin. In the peptide spanning
residues 250 –264 (Figure 6), the doubly-protonated
peptide (m/z 946.6) gives a large gap (369 Da) between
its y7 and y8 ions that indicates that Lys-257 is modified
and is a missed cleavage point. The doubly-protonated
peptide (m/z 941.1) spanning residues 438–452 gives a
less informative fragmentation spectrum (Figure 7), but
it is adequate to verify the sequence as well as the site of
modification, Lys-438 at the N-terminus of this peptide.
The fragmentation spectrum from the doubly-proto-
nated peptide (m/z 854.5) spanning residues 497–508
(Figure 8) gives a diagnostic mass difference of 369 Da
between the doubly-charged y10 ion and the singly-
charged y9 ion that definitively identifies the site of
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Figure 5. MS/MS spectrum of the AA# 123-138 containing
peptide atm/z 1119.8 confirms that Lys-130 is modified with biotin
reagent.modification as Lys-499, another missed cleavage point.
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(m/z 1382.7) spanning residues 598 – 609 (Figure 9) gives
a useful set of b ions (b4, b5, and b7–12) that confirms the
sequence and suggests modification at Lys-598.
A peptide with a mass corresponding to a peptide
spanning residues 301–310 with a modified lysine was
also identified. However, the fragmentation spectra
suggest instead that it is a peptide spanning residues
299–310. By coincidence, the mass shift associated with
a biotin-labeled 2-aminoadipic semi-aldehyde residue
(lysine oxidation product) is equal to the combined
masses of a leucine/isoleucine and a lysine. In HSA,
residues 299 and 300 are a leucine and a lysine (residue
298 is another lysine and provides a trypsin cleavage
point). Therefore, a peptide spanning residues 301–310
with a modified lysine and one missed cleavage point
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Figure 6. MS/MS spectrum for m/z 946.6 shows that the domi-
nant fragments, yn (n  5-11), arise from the biotinylated Lys-257
containing peptide (AA# 250-264).
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Figure 7. MS/MS spectrum of the AA# 438-452 containing
peptide at m/z 941.1 supports that Lys-438 is modified with biotin
reagent.has the same nominal mass as a peptide spanning
residues 299–310 with no modifications and two missed
cleavage points. The MS/MS data on this peptide are
not conclusive and do not definitively indicate a lysine
modification. We found no evidence for the conversion
of arginine to glutamic semi-aldehyde under these
conditions, but tyrosine chlorination was found at sev-
eral sites as well as a very weak signal for a proline
carbonylation at a single site.
Discussion
Carbonyl formation in HSA is extremely selective
under both sets of oxidation conditions. The protein
contains 59 lysine residues, most of which are on the
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identified two lysines that were modified by MCO. In
oxidations using HOCl, only five modified lysine
residues were definitively identified, none of which
overlapped with the MCO modification sites. Clearly,
some structural features in the protein are directing
the oxidation and causing the preferential modifica-
tion of selected lysines. Possibly some level of protein
denaturation occurs during the oxidation, disrupting
the structure, but this is less likely under the MCO
conditions where oxidation levels are low.
In the case of MCO, one might expect that there
would be a metal binding site near the location of the
lysine modification. HSA is known to bind transition
metals and the N-terminus, including His-27, has
been identified as a Cu 2 /Ni 2 binding site [49 –51].
In addition, there are data that suggest other binding
sites in HSA [52–54]. His-91 and His-271 have been
suggested as ligands for a Zn 2 binding site [55].
His-129 and His-170 also have been suggested as
ligands for transition-metal ions [52]. Crystal struc-
tures are available [46, 47] and recent work has
shown that these structures are consistent with data
obtained in solution for the protein [56]. In the crystal
structures, Lys-97 is located near the residues of the
N-terminus of the secreted protein, but not in the
region of the proposed binding site (i.e., near His-27).
Although residues 1–28 are not included in the crys-
tal structure, the position of the next residue, Ser-29,
suggests that the N-terminal residues of the secreted
protein (i.e., His-27) would be far from Lys-97. In fact,
Ser-29 is over 10 Å from Lys-97. There are no histi-
dines on the surface of the protein in the vicinity of
Lys-97. The most notable structural feature near
Lys-97 is a collection of acidic residues and an
asparagine, Glu-84, Asn-85, and Asp-96, which could
work together to provide a metal binding site. A
similar situation is seen with Lys-186. There are no
histidines on the surface near this lysine, but a group
of acidic residues is located in the vicinity (Glu-41,
Glu-155, and Glu-156) and could provide a metal
binding site for the oxidation reaction. Again, none of
the previously proposed binding sites is associated
with this residue. However, the lack of lysine oxida-
tion in the vicinity of the proposed metal binding
sites (specifically, the Cu/Ni site identified by Laus-
sac and Sarkar [50] and the Zn site identified by
Sadler et al. [49] is not surprising because neither of
these sites offers a nearby, exposed lysine. The po-
tential metal binding sites that we have identified
near the modified lysines are not truly optimal, but
the combination of modest metal binding and the
close proximity of an exposed lysine could make
these sites favorable for oxidation leading to carbonyl
formation. One might argue that other functional
groups in the protein are competing for the oxidant
and therefore the site selectivity is partially driven by
the presence or absence of nearby, easily-oxidized
groups (i.e., some lysines are protected by havingresidues such as methionine in close proximity).
However, HSA has only six methionines in its ex-
pressed form and only eight of the lysines in HSA are
within 7 Å of any of these methionines. There is only
one free cysteine in HSA and it is not near any lysines
(7 Å). Consequently, most of the lysines are not
protected in this way. In any case, the present results
indicate that Lys-97 and Lys-186 are kinetically the
most reactive residues for carbonyl formation in HSA
treated under MCO conditions. Possibly, modified
peptides with relatively weak signals were not de-
tected in our data-dependent scans, but we have
manually probed for specific, likely peptides in the
LC runs and not found additional modifications
(lysine or arginine). Consequently, apparently other
carbonyl products occur in considerably lower con-
centrations than the two that we have directly iden-
tified.
In the protein treated with HOCl, the identified sites
have some common features. The major one is the
presence of at least one, nearby acidic residue (Asp or
Glu) that could form a salt bridge to the lysine that is
oxidized. For Lys-257, the acid group of Asp-261 is
nearby as well as the functional groups of Glu-254 and
Tyr-287. In the case of Lys-438, Glu-516 and Tyr-435 are
close to the lysine’s amino group. For Lys-499, there is
a close interaction with the acid group of Glu-503 as
well as longer distance one with Asp-495. Lys-598 can
interact with Glu-595 or Glu-594. The situation is less
clear with Lys-130 because the crystal structure does not
indicate any specific interactions for the lysine amino
group; however, Glu-124 and Asp-132 are in close
proximity and salt bridge interactions could be devel-
oped with relatively minor conformation changes. The
need for a nearby proton donor/acceptor is consistent
with the mechanism of amine oxidation by HOCl [57].
First, the ammonium ion of the lysine side-chain must
be converted to a free amine by deprotonation. This
step frees the nitrogen lone pair to interact with the
oxygen of HOCl. Second, proton transfers are involved
in the oxygen addition process and the formation of the
initial hydroxylamine intermediate and its subsequent
conversion to an imine. Each of these steps would be
aided by the presence of one or more nearby proton
acceptor/donors (i.e., acidic residues). However, this
type of structural motif is not completely unique to
these sites and it is not clear what other factors distin-
guish them from the other lysines with nearby acidic
residues. In general, apparently there is much less
selectivity in the HOCl oxidations and factors such as
surface accessibility are playing a role also. Because
oxidation levels are relatively high in the HOCl sam-
ples, there is also the possibility that highly modified
peptides (i.e., multiple oxidation sites) would not be
identified in the data analysis. Moreover, we have some
evidence that there are additional lysine modification
sites in the HOCl samples that yield signals too weak to
be identified using our present LC/MS equipment and
data analysis strategy.
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aldehyde suggests that this process is slower than lysine
oxidation in HSA when MCO and HOCl are the oxi-
dants. Possibly, arginine oxidation is occurring to some
extent, but is below our present detectability level. In
our mass spectrometry method, low concentration spe-
cies that coelute with higher concentration species are
neglected in the scanning routine and therefore ignored
in the analysis. With respect to quantitation, our
labeling/mass spectrometric analysis only provides a
crude measure of relative oxidation yields based on the
intensity of the modified peptide in the spectrum.
Although we had relatively high levels of carbonyl
formation based on the 2,4-DNPH assays (3–8 carbon-
yls for every protein molecule), the intensity of the
biotin-labeled peptides was relatively weak. This may
be the result of poor ionization of these species or a poor
conversion of these species to biotinylated, tryptic pep-
tides. Methods that include quantitation and higher
sensitivity are under development in the laboratory and
will be used to address these questions.
Conclusions
In this study, the specific sites of carbonyl formation in
proteins subjected to oxidative stress have been identi-
fied. The generation of protein carbonyls in HSA by
metal-catalyzed oxidation (MCO) is highly selective
and only two of the 59 lysine residues were identified
by our approach as being oxidized to 2-aminoadipic
semi-aldehyde. Each of these sites appears to have
nearby residues capable of binding a metal ion. With
HOCl, five different sites were identified by our meth-
odology. Each of these sites was characterized by a
strong interaction with a nearby acidic residue. The fact
that only a subset of lysine residues was affected and
that the site of attack depends on the nature of the
oxidant, points to processes with specific structural
requirements. Given that there is strong site selectivity
in the oxidation of a given protein, it is not surprising
that protein carbonyl formation is only realized in a
subset of proteins subjected in vivo to oxidative stress.
The present data for HSA are not sufficiently general or
representative to define specific structural motifs that
are necessary for the preferential carbonylation of pro-
teins under oxidative stress. Studies with other proteins
are underway as well as experiments aimed at quanti-
fying oxidation at particular sites in a protein. The
results will be reported shortly.
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